What Is Ketamine Therapy?
Ketamine has a long history in medicine. Its emerging role in mental health is more recent, more nuanced, and frequently misunderstood. This page summarizes what is established, what is exploratory, and where careful reading matters.
What ketamine is — and what it isn't
A short primer on ketamine's history as an anesthetic and its more recent role in mental health research.
Is ketamine therapy the same as recreational ketamine?+
No. Therapeutic use takes place under medical supervision with proper screening, dosing, monitoring, and integration. Recreational use carries very different risks and is outside the scope of this resource.
Is it a psychedelic?+
Ketamine is a dissociative anesthetic. Subjective experiences can overlap with classical psychedelics, but the pharmacology is distinct.
A brief history
Ketamine was developed in the 1960s and has been used worldwide as an anesthetic. Its safety profile in supervised medical use is well established for anesthesia. Interest in subanesthetic doses for mental health emerged decades later, driven by observations of rapid antidepressant effects in certain patients.
Why it is studied for mental health
Most conventional antidepressants take weeks to reach full effect. Subanesthetic ketamine has been observed to reduce depressive symptoms within hours to days for some patients with treatment-resistant depression — a finding that reshaped how researchers think about rapid-acting treatments.
How it is delivered
Therapeutic protocols vary. Common delivery methods include intravenous (IV) infusion, intramuscular (IM) injection, intranasal esketamine (Spravato), and oral lozenges in some programs. Each method differs in onset, duration, regulation, and clinical context.
Regulatory context
Esketamine is FDA-approved for treatment-resistant depression within a restricted program. Generic ketamine for mental health is generally administered off-label, which is legal but requires careful informed consent and clinician oversight.
What this resource is not
Ketalux does not provide treatment, prescribe medication, or recommend specific clinics. We summarize public research and clinical context to help readers ask better questions of qualified professionals.
Frequently asked questions
Is ketamine therapy FDA-approved?+
Ketamine itself is FDA-approved as an anesthetic. Esketamine (Spravato) is FDA-approved as a prescription nasal spray for treatment-resistant depression under restricted programs. Most other 'ketamine therapy' is delivered off-label and varies in setting and protocol.
How is it different from recreational ketamine use?+
Therapeutic use occurs under medical supervision with dosing, monitoring, screening, and integration appropriate to a clinical setting. Recreational use carries significantly different risks and is outside the scope of this educational resource.
Is it a psychedelic therapy?+
Ketamine produces dissociative effects rather than the classic psychedelic effects of compounds like psilocybin. Some clinicians group these therapies together; pharmacologically, they are distinct.
References
- FDA label and program information for esketamine (Spravato). U.S. Food and Drug Administration
- Overview of ketamine for treatment-resistant depression. National Institute of Mental Health
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.